Health Care & Life Sciences » Pharmaceuticals | Bohai Pharmaceuticals Group Inc.

Bohai Pharmaceuticals Group Inc. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
59,264.70
81,328.60
137,372.50
151,792.90
175,086.20
Cost of Goods Sold (COGS) incl. D&A
10,202.60
20,192.30
36,111.20
39,809.60
44,917.50
Gross Income
49,062.10
61,136.30
101,261.30
111,983.30
130,168.70
SG&A Expense
30,335.90
34,513.60
72,889.80
83,416.60
97,757.40
EBIT
12,846.80
18,891.30
28,371.50
28,566.70
32,411.40
Unusual Expense
925.10
3,908.60
273.40
477.30
-
Non Operating Income/Expense
126.60
15.60
10.20
16.80
1,246.70
Interest Expense
1,437.00
4,097.70
11,194.30
1,967.50
2,286.70
Pretax Income
12,461.50
18,769.90
16,962.90
26,143.80
31,555.30
Income Tax
3,404.50
4,765.00
7,314.90
7,020.30
9,666.10
Consolidated Net Income
9,057.00
14,004.90
9,648.00
19,123.50
21,889.20
Net Income
9,057.00
14,004.90
9,648.00
19,123.50
21,889.20
Net Income After Extraordinaries
9,057.00
14,004.90
9,648.00
19,123.50
21,889.20
Net Income Available to Common
9,057.00
14,004.90
9,648.00
19,123.50
21,889.20
EPS (Basic)
0.55
0.75
0.54
0.91
1.02
Basic Shares Outstanding
14,722.10
17,198.90
17,861.10
17,861.10
17,964.70
EPS (Diluted)
0.55
0.75
0.54
0.91
1.02
Diluted Shares Outstanding
17,569.30
22,423.90
17,861.10
22,093.30
21,983.50
EBITDA
13,157.40
19,429.40
32,702.10
33,926.20
37,934.90
Other Operating Expense
5,879.50
7,731.40
-
-
-
Non-Operating Interest Income
-
52.10
69.30
38.70
184.00

About Bohai Pharmaceuticals Group

View Profile
Address
No. 9 Daxin Road
Yantai Shandong 264000
China
Employees -
Website -
Updated 09/14/2018
Bohai Pharmaceuticals Group, Inc. engages in the production, manufacture, and distribution of herbal pharmaceuticals based on traditional Chinese medicine. Its products include lung nourishing syrup, tongbi capsules, tongbi tablets, zhuangyuanshenhailong medicinal wine, bazhenyimu cream, fangfengtongsheng granule, and zhengxintai capsules. The company was founded on January 9, 2008 and is headquartered in Yantai, China.